Copyright
©The Author(s) 2019.
World J Gastroenterol. Feb 7, 2019; 25(5): 622-631
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622
Figure 1 Flow diagram of the study population.
HCC: Hepatocellular carcinoma; OM: Other non-hepatocellular carcinoma malignancy.
- Citation: Zhang T, Huang ZX, Wei Y, Jiang HY, Chen J, Liu XJ, Cao LK, Duan T, He XP, Xia CC, Song B. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? World J Gastroenterol 2019; 25(5): 622-631
- URL: https://www.wjgnet.com/1007-9327/full/v25/i5/622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i5.622